1.00 / AMA PRA Category 1 CreditTM 1.00 / CE for Nurse Practitioners
Jointly provided by Global Education Group and Physicians' Education Resource®, LLC (PER®)
This activity is supported by an independent medical educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive disease with a complicated diagnostic procedure. The challenge of IPF treatments highlights the importance of the multidisciplinary nature of this condition, stressing the need for a collaboration between many healthcare professionals involved in the care of patients with IPF. Our expert panel will provide healthcare professionals with knowledge about IPF, the diagnostic process, guideline and evidence-based individualized treatment plans, and the importance of a multidisciplinary, patient-centered approach to improve the quality of life for patients with IPF.
Pulmonologists, radiologists, primary care physicians, physician assistants, nurse practitioners, and other healthcare providers interested in IPF
At the conclusion of this activity, participants should be better able to:
Review strategies for confirming an IPF diagnosis, including the utility of high-resolution computed tomography and surgical lung biopsy
Discuss the importance of a multidisciplinary approach to IPF diagnosis
Integrate guideline-recommended care and evidence from clinical and real-world studies to develop individualized treatment plans for patients with IPF
Identify opportunities to provide individualized management for patients with shared decision-making in a patient-centered approach
Disclosure of Conflicts of Interest Policy
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Moderator Peter Salgo, MD Professor, Medicine and Anesthesiology Columbia University College of Physicians and Surgeons Associate Director, Surgical Intensive Care NewYork-Presbyterian Hospital New York, NY
Dr. Salgo has no relevant financial relationships with commercial interests to disclose.
Chair Fernando J. Martinez, MD, MS Chief, Division of Pulmonary and Critical Care Bruce Webster Professor of Medicine Joan and Sandford Weill Department of Medicine Weill Cornell Medical College NewYork-Presbyterian Hospital/Weill Cornell Medical Center New York, NY
Dr. Martinez discloses the following: Grant/research support: AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim Speaker's Bureau: Boehringer Ingelheim, Miller, NACE, Prime, Up To Date, Web MD, Novartis Consultant: AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Proterix Bio, Genentech, Novartis, Pearl, Theravance
Faculty Lake D. Morrison, MD Associate Professor of Medicine Director, Interstitial Lung Disease Clinic Duke University Medical Center Durham, NC
Dr. Morrison discloses the following: Grant/Research Support: Boehringer Ingelheim Consultant: Boehringer Ingelheim, Genentech Speakers Bureau: Boehringer Ingelheim
Mary Salvatore, MD, MBA Associate Professor of Radiology Mount Sinai Medical Center New York, NY
Dr. Salvatore discloses the following: Speaker’s Bureau: Boehringer Ingelheim, Genentech, Rockpointe
Accredited Provider Disclosure
Global Education Group Planning Staff—Kristen Delisi, NP, Lindsay Borvansky, Andrea Funk, and Liddy Knight have no relevant financial relationships with commercial interests to disclose.
Publishing Staff Disclosures
Physicians' Education Resource®, LLC (PER®) Planning Staff—David Heckard, Jyotiben Arya, PharmD, RPh, and Katie Pierson have no relevant financial relationships with commercial interests to disclose.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Physicians’ Education Resource®, LLC (PER®). Global is accredited by the ACCME to provide continuing medical education for physicians.
Global Education Group designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurse Practitioners
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Physicians’ Education Resource®, LLC. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024.
This activity is approved for 1.00 contact hour, which includes 0 hour(s) of pharmacology.
Activity ID # 2409E
This activity was planned in accordance with AANP CE Standards and Policies.
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and Physicians’ Education Resource, LLC® (PER®) do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.